Proof Looks Different at Every Stage: Interview with Former SpectraWAVE CEO Eman Namati

Transitioning from a technical or academic background to a CEO role requires shifting focus from optimizing technology to managing commercial viability, team dynamics, and strategic trade-offs. Success in medical device startups hinges on balancing technical innovation with clinical workflow integration, often requiring early, trust-based collaboration with clinicians. Founders must navigate the complexities of clinical evidence generation, recognizing that regulatory clearance differs significantly from the evidence needed for market adoption. Furthermore, capital-intensive ventures demand a "build for independence" mindset, where founders prioritize long-term value and sustainable infrastructure over immediate exit strategies. Eman Namati, former CEO of SpectraWAVE, highlights that while fundraising is a continuous process of relationship building, maintaining conviction in the company’s mission and selecting supportive, engaged partners are essential for navigating the inevitable challenges of the medtech landscape.